Mansur Ashham, Klee Yvonne, Popov Aron Frederik, Erlenwein Joachim, Ghadimi Michael, Beissbarth Tim, Bauer Martin, Hinz José
Department of Anesthesiology, University Medical Center, Georg August University, Goettingen, Niedersachsen, Germany.
Department of Cardiothoracic Transplantation & Mechanical Support, Royal Brompton and Harefield Hospital, Harefield, London, UK.
BMJ Open. 2015 Jan 6;5(1):e006616. doi: 10.1136/bmjopen-2014-006616.
To investigate whether common infection foci (pulmonary, intra-abdominal and primary bacteraemia) are associated with variations in mortality risk in patients with sepsis.
Prospective, observational cohort study.
Three surgical intensive care units (ICUs) at a university medical centre.
A total of 327 adult Caucasian patients with sepsis originating from pulmonary, intra-abdominal and primary bacteraemia participated in this study.
The patients were followed for 90 days and mortality risk was recorded as the primary outcome variable. To monitor organ failure, sepsis-related organ failure assessment (Sequential Organ Failure Assessment, SOFA) scores were evaluated at the onset of sepsis and throughout the observational period as secondary outcome variables.
A total of 327 critically ill patients with sepsis were enrolled in this study. Kaplan-Meier survival analysis showed that the 90-day mortality risk was significantly higher among patients with primary bacteraemia than among those with pulmonary and intra-abdominal foci (58%, 35% and 32%, respectively; p=0.0208). To exclude the effects of several baseline variables, we performed multivariate Cox regression analysis. Primary bacteraemia remained a significant covariate for mortality in the multivariate analysis (HR 2.10; 95% CI 1.14 to 3.86; p=0.0166). During their stay in the ICU, the patients with primary bacteraemia presented significantly higher SOFA scores than those of the patients with pulmonary and intra-abdominal infection foci (8.5±4.7, 7.3±3.4 and 5.8±3.5, respectively). Patients with primary bacteraemia presented higher SOFA-renal score compared with the patients with other infection foci (1.6±1.4, 0.8±1.1 and 0.7±1.0, respectively); the patients with primary bacteraemia required significantly more renal replacement therapy than the patients in the other groups (29%, 11% and 12%, respectively).
These results indicate that patients with sepsis with primary bacteraemia present a higher mortality risk compared with patients with sepsis of pulmonary or intra-abdominal origins. These results should be assessed in patients with sepsis in larger, independent cohorts.
探讨常见感染灶(肺部、腹腔内及原发性菌血症)是否与脓毒症患者死亡风险的差异相关。
前瞻性观察性队列研究。
一所大学医学中心的三个外科重症监护病房(ICU)。
共有327例源自肺部、腹腔内及原发性菌血症的成年白种人脓毒症患者参与了本研究。
对患者进行90天随访,将死亡风险记录为主要结局变量。为监测器官功能衰竭,在脓毒症发作时及整个观察期评估脓毒症相关器官功能衰竭评估(序贯器官衰竭评估,SOFA)评分作为次要结局变量。
本研究共纳入327例重症脓毒症患者。Kaplan-Meier生存分析显示,原发性菌血症患者的90天死亡风险显著高于肺部和腹腔内感染灶患者(分别为58%、35%和32%;p = 0.0208)。为排除几个基线变量的影响,我们进行了多因素Cox回归分析。在多因素分析中,原发性菌血症仍然是死亡的显著协变量(HR 2.10;95% CI 1.14至3.86;p = 0.0166)。在ICU住院期间,原发性菌血症患者的SOFA评分显著高于肺部和腹腔内感染灶患者(分别为8.5±4.7、7.3±3.4和5.8±3.5)。与其他感染灶患者相比,原发性菌血症患者的SOFA-肾脏评分更高(分别为1.6±1.4、0.8±1.1和0.7±1.0);原发性菌血症患者需要肾脏替代治疗的比例显著高于其他组患者(分别为29%、11%和12%)。
这些结果表明,与肺部或腹腔内源性脓毒症患者相比,原发性菌血症脓毒症患者的死亡风险更高。这些结果应在更大规模的独立队列中的脓毒症患者中进行评估。